Works matching IS 00281298 AND DT 2009 AND VI 379 AND IP 4

Results: 15

Suitability of muscarinic acetylcholine receptor antibodies for immunohistochemistry evaluated on tissue sections of receptor gene-deficient mice.

Published in:

Naunyn-Schmiedeberg's Archives of Pharmacology, 2009, v. 379, n. 4, p. 389, doi. 10.1007/s00210-008-0365-9

By:

Jositsch, Gitte;
Papadakis, Tamara;
Haberberger, Rainer;
Wolff, Miriam;
Wess, Jürgen;
Kummer, Wolfgang

Publication type:

Article

Positive allosteric modulatory effects of ajulemic acid at strychnine-sensitive glycine α1- and α1β-receptors.

Published in:

Naunyn-Schmiedeberg's Archives of Pharmacology, 2009, v. 379, n. 4, p. 371, doi. 10.1007/s00210-008-0366-8

By:

Ahrens, Jörg;
Leuwer, Martin;
Demir, Reyhan;
Krampfl, Klaus;
Roche, Jeanne;
Foadi, Nilufar;
Karst, Matthias;
Haeseler, Gertrud

Publication type:

Article

Phosphodiesterases PDE3 and PDE4 jointly control the inotropic effects but not chronotropic effects of (−)-CGP12177 despite PDE4-evoked sinoatrial bradycardia in rat atrium.

Published in:

Naunyn-Schmiedeberg's Archives of Pharmacology, 2009, v. 379, n. 4, p. 379, doi. 10.1007/s00210-008-0367-7

By:

Galindo-Tovar, Alejandro;
Vargas, Maria;
Kaumann, Alberto

Publication type:

Article

Ten commercial antibodies for alpha-1-adrenergic receptor subtypes are nonspecific.

Published in:

Naunyn-Schmiedeberg's Archives of Pharmacology, 2009, v. 379, n. 4, p. 409, doi. 10.1007/s00210-008-0368-6

By:

Jensen, Brian;
Swigart, Philip;
Simpson, Paul

Publication type:

Article

Structural determinants of inhibitor interaction with the human organic cation transporter OCT2 ( SLC22A2).

Published in:

Naunyn-Schmiedeberg's Archives of Pharmacology, 2009, v. 379, n. 4, p. 337, doi. 10.1007/s00210-008-0369-5

By:

Zolk, Oliver;
Solbach, Thomas;
König, Jörg;
Fromm, Martin

Publication type:

Article

Effects of gabapentin and pregabalin on K+-evoked 3H-GABA and 3H-glutamate release from human neocortical synaptosomes.

Published in:

Naunyn-Schmiedeberg's Archives of Pharmacology, 2009, v. 379, n. 4, p. 361, doi. 10.1007/s00210-008-0370-z

By:

Brawek, B.;
Löffler, M.;
Weyerbrock, A.;
Feuerstein, T.

Publication type:

Article

Phosphorylation of phospholamban and troponin I through 5-HT4 receptors in the isolated human atrium.

Published in:

Naunyn-Schmiedeberg's Archives of Pharmacology, 2009, v. 379, n. 4, p. 349, doi. 10.1007/s00210-008-0371-y

By:

Gergs, Ulrich;
Neumann, Joachim;
Simm, Andreas;
Silber, Rolf-Edgar;
Remmers, Freerk;
Läer, Stephanie

Publication type:

Article

Modulation of butyrate transport in Caco-2 cells.

Published in:

Naunyn-Schmiedeberg's Archives of Pharmacology, 2009, v. 379, n. 4, p. 325, doi. 10.1007/s00210-008-0372-x

By:

Gonçalves, Pedro;
Araújo, João;
Pinho, Maria;
Martel, Fátima

Publication type:

Article

Should we be cautious on the use of commercially available antibodies to dopamine receptors?

Published in:

Naunyn-Schmiedeberg's Archives of Pharmacology, 2009, v. 379, n. 4, p. 413, doi. 10.1007/s00210-008-0384-6

By:

Bodei, Serena;
Arrighi, Nicola;
Spano, PierFranco;
Sigala, Sandra

Publication type:

Article

Distribution and regulation of protein expression of the free fatty acid receptor GPR120.

Published in:

Naunyn-Schmiedeberg's Archives of Pharmacology, 2009, v. 379, n. 4, p. 427, doi. 10.1007/s00210-008-0390-8

By:

Miyauchi, Satoshi;
Hirasawa, Akira;
Iga, Tomoyo;
Liu, Ning;
Itsubo, Chisato;
Sadakane, Keiko;
Hara, Takafumi;
Tsujimoto, Gozoh

Publication type:

Article

Where is TRPV1 expressed in the bladder, do we see the real channel?

Published in:

Naunyn-Schmiedeberg's Archives of Pharmacology, 2009, v. 379, n. 4, p. 421, doi. 10.1007/s00210-008-0391-7

By:

Everaerts, Wouter;
Sepúlveda, M.;
Gevaert, Thomas;
Roskams, Tania;
Nilius, Bernd;
Ridder, Dirk

Publication type:

Article

Lack of specificity of antibodies directed against human beta-adrenergic receptors.

Published in:

Naunyn-Schmiedeberg's Archives of Pharmacology, 2009, v. 379, n. 4, p. 403, doi. 10.1007/s00210-009-0392-1

By:

Hamdani, Nazha;
Velden, Jolanda

Publication type:

Article

Lack of specificity of commercially available antisera against muscarinergic and adrenergic receptors.

Published in:

Naunyn-Schmiedeberg's Archives of Pharmacology, 2009, v. 379, n. 4, p. 397, doi. 10.1007/s00210-009-0393-0

By:

Pradidarcheep, Wisuit;
Stallen, Jan;
Labruyère, Wil;
Dabhoiwala, Noshir;
Michel, Martin;
Lamers, Wouter

Publication type:

Article

Analyzing the validity of GalR1 and GalR2 antibodies using knockout mice.

Published in:

Naunyn-Schmiedeberg's Archives of Pharmacology, 2009, v. 379, n. 4, p. 417, doi. 10.1007/s00210-009-0394-z

By:

Lu, Xiaoying;
Bartfai, Tamas

Publication type:

Article

How reliable are G-protein-coupled receptor antibodies?

Published in:

2009

By:

Michel, Martin;
Wieland, Thomas;
Tsujimoto, Gozoh

Publication type:

Editorial

Works matching IS 00281298 AND DT 2009 AND VI 379 AND IP 4

Suitability of muscarinic acetylcholine receptor antibodies for immunohistochemistry evaluated on tissue sections of receptor gene-deficient mice.

Positive allosteric modulatory effects of ajulemic acid at strychnine-sensitive glycine α<sub>1</sub>- and α<sub>1</sub>β-receptors.

Phosphodiesterases PDE3 and PDE4 jointly control the inotropic effects but not chronotropic effects of (−)-CGP12177 despite PDE4-evoked sinoatrial bradycardia in rat atrium.

Ten commercial antibodies for alpha-1-adrenergic receptor subtypes are nonspecific.

Structural determinants of inhibitor interaction with the human organic cation transporter OCT2 ( SLC22A2).

Effects of gabapentin and pregabalin on K<sup>+</sup>-evoked <sup>3</sup>H-GABA and <sup>3</sup>H-glutamate release from human neocortical synaptosomes.

Phosphorylation of phospholamban and troponin I through 5-HT<sub>4</sub> receptors in the isolated human atrium.

Modulation of butyrate transport in Caco-2 cells.

Should we be cautious on the use of commercially available antibodies to dopamine receptors?

Distribution and regulation of protein expression of the free fatty acid receptor GPR120.

Where is TRPV1 expressed in the bladder, do we see the real channel?

Lack of specificity of antibodies directed against human beta-adrenergic receptors.

Lack of specificity of commercially available antisera against muscarinergic and adrenergic receptors.

Analyzing the validity of GalR1 and GalR2 antibodies using knockout mice.

How reliable are G-protein-coupled receptor antibodies?